• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Run from Galderma Rx

Quote
anonymous said:
Making Nemo hard to get for IDN based docs or groups with tight links to IDNs was a very stupid idea. Have had several decline to use once they had to go outside their preferred Specialty Partner.
Click to expand...
Lol. Told Lenar this when she laid out the plan for this stupid thing. Restricted distribution will not work. David brown is equally stupid annd clueless. Wtf does a global guy know about us business. Our team is making all the classic mistakes which shows that this team has no experience. Some assholes are like it’s only been 6 weeks or 8 weeks or 10 weeks. These idiots don’t understand launch only happens once then people move on. Lenar knew she fucked up and left us with this rancid stinking shitpile. The woman sucks.
 




Can someone justify our spend in Rx right now. I have visibility into our finances and us spending > 100M on this crap is not justified. 2 cents - shuck the Aimee plan and bring in new people that actually know what the fuck they are doing. She ruined Galderma Rx and have idiots like Deb Hagan running the team. WHat is so hard here. Galderma is grat at firing people - fire these idiots and get a new team.
 




















Top Bottom
Back
Quote